Mereo BioPharma Group Plc (MREO)
0.3075
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.30
-0.01
(-2.44%)
After-Hours: 19:59
Mereo BioPharma Group Debt to Equity Ratio : 0.0243 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0243 |
| June 30, 2026 | 0.0359 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.0049 |
| September 30, 2025 | 0.0085 |
| June 30, 2025 | 0.0111 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.0124 |
| December 31, 2024 | 0.1054 |
| September 30, 2024 | 0.0921 |
| June 30, 2024 | 0.0783 |
| March 31, 2024 | 0.1405 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.034 |
| BioNTech SE | 0.0286 |
| Silence Therapeutics Plc | 0.0004 |
| Autolus Therapeutics Plc | 16.10 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 29.58M |
| Total Liabilities (Quarterly) | 5.872M |
| Shareholders Equity (Quarterly) | 23.71M |
| Current Ratio | 5.219 |
| Net Debt Paydown Yield | 0.01% |